ORIC Oric Pharmaceuticals, Inc. - Common Stock
$14.35
价格 · 八月 19, 2026
截至...的财报数据 八月 3, 2026
52周区间
$7–$15
92% of range
分析师评级
BUY
21 analysts
目标价
$21
+44% upside
P/E (TTM)
-10.3
ROE
-36.5%
净利润率
—
ORIC 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$14.35
市值
$1.49B
P/E (TTM)
-10.3
每股收益 (TTM)
$-1.47
营收 (TTM)
—
股息收益率
—
ROE
-36.5%
负债/权益
—
52周区间
$7 – $15
ORIC 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-1.47
2021-12-31
→
2025-12-31
自由现金流
$-112M
2020-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
ORIC
同行中位数
P/E (TTM)
-10.3
—
P/B (市净率)
3.9
3.6
Price / FCF (股价/自由现金流)
-13.3
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
ORIC
同行中位数
ROA
-37.9%
-40.9%
ROE
-36.5%
-47.9%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
ORIC
同行中位数
Current Ratio (流动比率)
14.1
8.3
Quick Ratio (速动比率)
2.2
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
ORIC
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
ORIC
同行中位数
ORIC 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
21 位分析师
- 强烈买入 9 42.9%
- 买入 10 47.6%
- 持有 2 9.5%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
12 位分析师 · 2026-08-19
中位数
$21.50
现在
$14.35
最低
$14.00
最高
$27.00
中位数目标
$21.50
+49.8%
平均目标
$20.67
+44.0%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.04%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.38 | $-0.37 | -0.01% |
| 2026年3月31日 | $-0.34 | $-0.33 | -0.01% |
| 2025年12月31日 | $-0.30 | $-0.37 | 0.07% |
| 2025年9月30日 | $-0.33 | $-0.41 | 0.08% |
| 2025年6月30日 | $-0.47 | $-0.45 | -0.02% |
| 2025年3月31日 | $-0.42 | $-0.52 | 0.10% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ORIC | $806M | -5.6 | — | — | -36.5% | — |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | — |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | — |
| TYRA | $1.41B | -13.1 | — | — | -42.7% | — |
| PURR | — | — | — | — | — | — |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| JBIO | $761M | -4.8 | — | — | -47.7% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 11
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $33M | $29M | $26M | $25M | $22M | $13M | $6M | |
| Operating Expenses | $143M | $143M | $111M | $92M | $79M | $74M | $29M | |
| Operating Income | $-143M | $-143M | $-111M | $-92M | $-79M | $-74M | $-29M | |
| Other Non-op | $14M | $15M | $10M | $3M | $156.0K | $483.0K | $2M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-129M | $-128M | $-101M | $-89M | $-79M | $-74M | $-27M | |
| EPS (Basic) | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 | · | · | |
| EPS (Diluted) | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 | · | · | |
| Shares (Basic) | 87,793,801 | 69,727,940 | 51,450,848 | 39,655,260 | 37,954,280 | · | · | |
| Shares (Diluted) | 87,793,801 | 69,727,940 | 51,450,848 | 39,655,260 | 37,954,280 | · | · | |
| EBITDA | $-143M | $-143M | $-111M | $-92M | $-79M | $-74M | · |
资产负债表 22
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $59M | $23M | $67M | $226M | $78M | $89M | |
| Short-term Investments | · | · | · | · | · | $215M | · | |
| Prepaid Expense | $7M | $6M | $4M | $4M | $4M | $3M | $840.0K | |
| Current Assets | $288M | $262M | $213M | $210M | $241M | $297M | $90M | |
| PP&E (Net) | $2M | $3M | $3M | $3M | $2M | $2M | $2M | |
| PP&E (Gross) | $10M | $10M | $9M | $9M | $7M | $6M | $6M | |
| Accum. Depreciation | $8M | $7M | $6M | $6M | $5M | $4M | $4M | |
| Other Non-current Assets | $7M | $9M | $10M | $12M | $12M | $319.0K | $2M | |
| Total Assets | $409M | $274M | $252M | $247M | $299M | $299M | $94M | |
| Accounts Payable | $4M | $2M | $944.0K | $1M | $2M | $757.0K | $152.0K | |
| Accrued Liabilities | $17M | $23M | $20M | $14M | $13M | $8M | $5M | |
| Current Liabilities | $20M | $25M | $20M | $15M | $15M | $9M | $5M | |
| Capital Leases | $4M | $6M | $7M | $9M | $10M | · | · | |
| Other Non-current Liabilities | $4M | $6M | $7M | $9M | $11M | $219.0K | · | |
| Total Liabilities | $25M | $31M | $28M | $25M | $26M | $9M | $6M | |
| Long-term Debt | · | · | · | · | $10M | · | · | |
| Common Stock | $11.0K | $7.0K | $6.0K | $5.0K | $4.0K | $4.0K | · | |
| Retained Earnings | $-692M | $-563M | $-435M | $-334M | $-245M | $-166M | $-93M | |
| AOCI | $786.0K | $379.0K | $258.0K | $-1M | $-103.0K | $-31.0K | · | |
| Stockholders' Equity | $384M | $243M | $224M | $222M | $273M | $290M | $-90M | |
| Liabilities + Equity | $409M | $274M | $252M | $247M | $299M | $299M | $94M | |
| Shares Outstanding | 98,528,949 | 71,021,855 | 54,865,553 | 45,089,537 | 39,430,120 | 36,672,415 | 1,984,222 |
现金流 9
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $25M | $20M | $15M | $14M | $13M | $5M | $1M | |
| Operating Cash Flow | $-111M | $-113M | $-86M | $-75M | $-60M | $-45M | $-24M | |
| CapEx | $712.0K | $1M | $849.0K | $2M | $939.0K | $667.0K | $768.0K | |
| Investing Cash Flow | $-148M | $22M | $-43M | $-109M | $158M | $-216M | $-768.0K | |
| Stock Issued | $244M | $125M | $85M | $25M | $50M | $271M | · | |
| Net Stock Activity | $244M | $125M | $85M | $25M | $50M | $133M | · | |
| Financing Cash Flow | $245M | $127M | $86M | $25M | $49M | $251M | $71M | |
| Net Change in Cash | $-14M | $36M | $-43M | $-159M | $148M | $-11M | $47M | |
| Free Cash Flow | $-112M | $-114M | $-87M | $-77M | $-60M | $-46M | · |
盈利能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -37.9% | -48.6% | -40.3% | -32.7% | -26.3% | -37.5% | · | |
| ROE | -36.5% | -49.5% | -42.7% | -40.8% | -27.9% | -31.1% | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.1 | 10.6 | 10.4 | 13.7 | 15.9 | 33.0 | · | |
| Quick Ratio | 2.2 | 2.4 | 1.1 | 4.3 | 14.9 | 32.6 | · |
估值 (TTM) 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-129M | $-128M | $-101M | $-89M | $-79M | $-74M | · | |
| Market Cap | $806M | $573M | $505M | $266M | $580M | $1.24B | · | |
| P/E | -5.6 | -4.4 | -4.7 | -2.6 | -7.1 | · | · | |
| P/B | 2.1 | 2.4 | 2.3 | 1.2 | 2.1 | 4.3 | · | |
| P / Tangible Book | 2.1 | 2.4 | 2.3 | 1.2 | 2.1 | 4.3 | · | |
| P / Cash Flow | -7.3 | -5.1 | -5.9 | -3.5 | -9.7 | -27.4 | · | |
| P / FCF | -7.2 | -5.0 | -5.8 | -3.4 | -9.6 | -27.0 | · | |
| Earnings Yield | -18.0% | -22.7% | -21.3% | -38.2% | -14.1% | · | · |
损益表 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $9M | $8M | $9M | $8M | $9M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | |
| Operating Expenses | $45M | $40M | $35M | $37M | $39M | $33M | $40M | $38M | $36M | $29M | $31M | $29M | $25M | $26M | $22M | $26M | |
| Operating Income | $-45M | $-40M | $-35M | $-37M | $-39M | $-33M | $-40M | $-38M | $-36M | $-29M | $-31M | $-29M | $-25M | $-26M | $-22M | $-26M | |
| Other Non-op | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $1M | $865.0K | |
| Net Income | $-41M | $-36M | $-31M | $-33M | $-36M | $-30M | $-36M | $-35M | $-32M | $-25M | $-28M | $-25M | $-23M | $-24M | $-21M | $-25M | |
| EPS (Basic) | $-0.38 | $-0.34 | $-0.25 | $-0.33 | $-0.47 | $-0.42 | $-0.52 | $-0.49 | $-0.45 | $-0.37 | $-0.49 | $-0.44 | $-0.50 | $-0.53 | $-0.52 | $-0.63 | |
| EPS (Diluted) | $-0.38 | $-0.34 | $-0.25 | $-0.33 | $-0.47 | $-0.42 | $-0.52 | $-0.49 | $-0.45 | $-0.37 | $-0.49 | $-0.44 | $-0.50 | $-0.53 | $-0.52 | $-0.63 | |
| Shares (Basic) | 108,012,388 | 105,472,766 | -160,326,367 | 98,953,331 | 78,126,257 | 71,040,580 | -138,512,709 | 70,542,684 | 70,348,414 | 67,349,551 | -96,695,752 | 57,402,226 | 45,654,208 | 45,090,166 | -78,833,750 | 39,575,660 | |
| Shares (Diluted) | 108,012,388 | 105,472,766 | -160,326,367 | 98,953,331 | 78,126,257 | 71,040,580 | -138,512,709 | 70,542,684 | 70,348,414 | 67,349,551 | -96,695,752 | 57,402,226 | 45,654,208 | 45,090,166 | -78,833,750 | 39,575,660 | |
| EBITDA | $-45M | $-40M | · | $-37M | $-39M | $-33M | · | $-38M | $-36M | $-29M | · | $-29M | $-25M | $-26M | · | $-26M |
资产负债表 20
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $56M | $46M | $50M | $76M | $49M | $59M | $44M | $50M | $56M | $23M | $26M | $104M | $59M | $67M | $29M | |
| Prepaid Expense | $9M | $8M | $7M | $8M | $9M | $8M | $6M | $7M | $8M | $7M | $4M | $5M | $4M | $4M | $4M | $5M | |
| Current Assets | $274M | $290M | $288M | $296M | $291M | $211M | $262M | $279M | $295M | $324M | $213M | $232M | $268M | $193M | $210M | $199M | |
| PP&E (Net) | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $10M | $10M | $10M | $11M | $11M | $11M | $10M | $10M | $10M | $9M | $9M | $10M | $10M | $9M | $9M | $9M | |
| Accum. Depreciation | $8M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $7M | $6M | $6M | $6M | $6M | |
| Other Non-current Assets | $6M | $7M | $7M | $7M | $8M | $8M | $9M | $10M | $9M | $9M | $10M | $10M | $11M | $11M | $12M | $12M | |
| Total Assets | $405M | $437M | $409M | $431M | $347M | $243M | $274M | $302M | $329M | $351M | $252M | $274M | $292M | $227M | $247M | $238M | |
| Accounts Payable | $4M | $3M | $4M | $3M | $3M | $5M | $2M | $4M | $2M | $3M | $944.0K | $4M | $3M | $2M | $1M | $2M | |
| Accrued Liabilities | $17M | $15M | $17M | $17M | $15M | $12M | $23M | $17M | $17M | $12M | $20M | $15M | $11M | $13M | $14M | $12M | |
| Current Liabilities | $21M | $18M | $20M | $20M | $18M | $18M | $25M | $21M | $20M | $15M | $20M | $19M | $15M | $15M | $15M | $13M | |
| Capital Leases | · | · | $4M | · | · | · | $6M | · | · | · | $7M | · | · | · | $9M | · | |
| Other Non-current Liabilities | $3M | $3M | $4M | $4M | $5M | $6M | $6M | $7M | $7M | $7M | $7M | $8M | $8M | $9M | $9M | $10M | |
| Total Liabilities | $23M | $21M | $25M | $24M | $23M | $23M | $31M | $28M | $27M | $22M | $28M | $27M | $23M | $24M | $25M | $23M | |
| Common Stock | $11.0K | $11.0K | $11.0K | $11.0K | $9.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | |
| Retained Earnings | $-770M | $-728M | $-692M | $-662M | $-629M | $-593M | $-563M | $-526M | $-492M | $-460M | $-435M | $-407M | $-381M | $-358M | $-334M | $-313M | |
| AOCI | $-1M | $-290.0K | $786.0K | $615.0K | $187.0K | $209.0K | $379.0K | $722.0K | $-256.0K | $-162.0K | $258.0K | $-369.0K | $-567.0K | $-499.0K | $-1M | $-2M | |
| Stockholders' Equity | $381M | $416M | $384M | $407M | $324M | $220M | $243M | $274M | $302M | $329M | $224M | $247M | $269M | $203M | $222M | $215M | |
| Liabilities + Equity | $405M | $437M | $409M | $431M | $347M | $243M | $274M | $302M | $329M | $351M | $252M | $274M | $292M | $227M | $247M | $238M | |
| Shares Outstanding | 103,636,424 | 103,486,412 | 98,528,949 | 97,278,032 | 86,187,328 | 71,078,511 | 71,021,855 | 70,559,183 | 67,672,303 | 67,420,338 | 54,865,553 | 54,540,715 | 54,532,171 | 45,091,215 | 45,089,537 | 39,576,047 |
现金流 9
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $7M | $6M | $6M | $7M | $7M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | |
| Operating Cash Flow | $-32M | $-32M | $-22M | $-25M | $-31M | $-33M | $-28M | $-29M | $-26M | $-30M | $-24M | $-20M | $-21M | $-21M | $-15M | $-19M | |
| CapEx | $356.0K | $2.0K | $227.0K | $35.0K | $63.0K | $387.0K | $219.0K | $418.0K | $333.0K | $218.0K | $57.0K | $77.0K | $405.0K | $310.0K | $287.0K | $401.0K | |
| Investing Cash Flow | $12M | $-18M | $17M | $-111M | $-77M | $22M | $43M | $23M | $18M | $-62M | $21M | $-58M | $-19M | $13M | $28M | $-685.0K | |
| Stock Issued | $0 | $61M | $0 | $110M | $134M | $0 | $0 | $0 | $0 | $125M | $0 | $226.0K | $85M | $0 | $25M | $-354.0K | |
| Net Stock Activity | · | $61M | · | · | · | $0 | · | · | · | $125M | · | · | · | · | · | · | |
| Financing Cash Flow | $828.0K | $61M | $2M | $109M | $134M | $11.0K | $575.0K | $126.0K | $816.0K | $125M | $453.0K | $31.0K | $85M | $0 | $25M | $1.0K | |
| Net Change in Cash | $-19M | $11M | $-4M | $-26M | $27M | $-10M | $15M | $-6M | $-7M | $33M | $-3M | $-77M | $45M | $-8M | $38M | $-20M | |
| Free Cash Flow | · | $-32M | · | · | · | $-33M | · | · | · | $-30M | · | · | · | $-21M | · | · |
盈利能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -11.0% | -10.5% | · | -8.9% | -10.8% | -10.1% | · | -12.0% | -10.3% | -8.7% | · | -10.0% | -8.3% | -9.6% | · | -9.0% | |
| ROE | -11.8% | -11.3% | · | -9.6% | -11.6% | -10.9% | · | -13.3% | -11.2% | -9.4% | · | -11.0% | -9.1% | -10.5% | · | -9.8% |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.2 | 16.3 | · | 14.6 | 16.1 | 12.0 | · | 13.2 | 15.1 | 21.3 | · | 12.3 | 18.5 | 13.0 | · | 15.0 | |
| Quick Ratio | 1.8 | 3.2 | · | 2.5 | 4.2 | 2.8 | · | 2.1 | 2.6 | 3.7 | · | 1.4 | 7.1 | 4.0 | · | 2.2 |
估值 (TTM) 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-146M | $-135M | · | $-134M | $-133M | $-122M | · | $-117M | $-105M | $-97M | · | $-97M | $-92M | $-92M | · | $-87M | |
| Market Cap | $1.12B | $1.31B | · | $1.17B | $875M | $397M | · | $723M | $478M | $927M | · | $330M | $423M | $257M | · | $127M | |
| P/E | -7.1 | -8.1 | · | -7.0 | -5.5 | -3.2 | · | -5.9 | -4.0 | -7.5 | · | -2.9 | -3.6 | -2.5 | · | -1.5 | |
| P/B | 2.9 | 3.2 | · | 2.9 | 2.7 | 1.8 | · | 2.6 | 1.6 | 2.8 | · | 1.3 | 1.6 | 1.3 | · | 0.6 | |
| P / Tangible Book | 2.9 | 3.2 | · | 2.9 | 2.7 | 1.8 | · | 2.6 | 1.6 | 2.8 | · | 1.3 | 1.6 | 1.3 | · | 0.6 | |
| P / Cash Flow | · | -40.4 | · | · | · | -12.2 | · | · | · | -30.7 | · | · | · | -12.5 | · | · | |
| P / FCF | · | -40.4 | · | · | · | -12.0 | · | · | · | -30.5 | · | · | · | -12.3 | · | · | |
| Earnings Yield | -14.0% | -12.3% | · | -14.2% | -18.0% | -31.0% | · | -17.1% | -24.9% | -13.4% | · | -34.7% | -28.0% | -39.6% | · | -68.8% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 净收入 | $-129M | $-128M | $-101M | $-89M | $-79M |
| 稀释后每股收益 (EPS) | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 14.1 | 10.6 | 10.4 | 13.7 | 15.9 |
| 速动比率 | 2.2 | 2.4 | 1.1 | 4.3 | 14.9 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-112M | $-114M | $-87M | $-77M | $-60M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 192 家申报者 · $1.1B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 40 (-3 与上一季度对比) | 29 (+11 与上一季度对比) | 68 (+17 与上一季度对比) | 44 (-18 与上一季度对比) | +5.7M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Nextech Invest Ltd. | $77571359 | 7162637 | 6.91% | 股份 |
| EcoR1 Capital, LLC | $72865496 | 6728116 | 6.49% | 股份 |
| VIKING GLOBAL INVESTORS LP | $55522832 | 5126762 | 4.95% | 股份 |
| STATE STREET CORP | $53002020 | 4894000 | 4.72% | 股份 |
| SR One Capital Management, LP | $49984609 | 4615384 | 4.45% | 股份 |
| Venrock Adviser, LLC | $46783055 | 4319765 | 4.17% | 股份 |
| NEA Management Company, LLC | $44604665 | 4118621 | 3.97% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $42791160 | 3951169 | 3.81% | 股份 |
| Nextech Invest Ltd. | $42655712 | 5285714 | 3.80% | 股份 |
| AIHC Capital Management Ltd | $41462222 | 3828460 | 3.69% | 股份 |
| Column Group LLC | $38346615 | 3540777 | 3.42% | 股份 |
| ALKEON CAPITAL MANAGEMENT LLC | $33845158 | 3125130 | 3.01% | 股份 |
| VANGUARD GROUP INC | $32441356 | 3965936 | 2.89% | 股份 |
| CITADEL ADVISORS LLC | $23789416 | 2196622 | 2.12% | 股份 |
| First Turn Management, LLC | $21847186 | 2017284 | 1.95% | 股份 |
| ORBIMED ADVISORS LLC | $21822450 | 2015000 | 1.94% | 股份 |
| Integral Health Asset Management, LLC | $20577000 | 1900000 | 1.83% | 股份 |
| MPM BIOIMPACT LLC | $20383814 | 1882162 | 1.82% | 股份 |
| Vivo Capital, LLC | $20022352 | 1848786 | 1.78% | 股份 |
| GOLDMAN SACHS GROUP INC | $19593582 | 1809195 | 1.75% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $19414443 | 1792258 | 1.73% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $18476857 | 1706081 | 1.65% | 股份 |
| FMR LLC | $14205494 | 1311680 | 1.27% | 股份 |
| Woodline Partners LP | $13510587 | 1247515 | 1.20% | 股份 |
| ALGERT GLOBAL LLC | $13161623 | 1215293 | 1.17% | 股份 |
| BRAIDWELL LP | $13153468 | 1214540 | 1.17% | 股份 |
| Candriam S.C.A. | $12764594 | 1179768 | 1.14% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $11392109 | 1051903 | 1.01% | 股份 |
| Defilade Capital Management, L.P. | $11346483 | 1047690 | 1.01% | 股份 |
| Siren, L.L.C. | $10912037 | 1007575 | 0.97% | 股份 |
| Euclidean Capital LLC | $10715310 | 989410 | 0.95% | 股份 |
| ROYCE & ASSOCIATES LP | $10609761 | 979664 | 0.94% | 股份 |
| EVENTIDE ASSET MANAGEMENT, LLC | $10337886 | 954768 | 0.92% | 股份 |
| Qube Research & Technologies Ltd | $8604890 | 794542 | 0.77% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $8154806 | 752983 | 0.73% | 股份 |
| Jones Hill Capital LP | $8093400 | 747313 | 0.72% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $8001995 | 738873 | 0.71% | 股份 |
| NEXTBio Capital Management LP | $7647323 | 706124 | 0.68% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $7556026 | 697694 | 0.67% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7340823 | 677823 | 0.65% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6808626 | 628682 | 0.61% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $6537681 | 603664 | 0.58% | 股份 |
| ArrowMark Colorado Holdings LLC | $6312536 | 582875 | 0.56% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $6130192 | 566038 | 0.55% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $5614922 | 518460 | 0.50% | 股份 |
| SUPERSTRING CAPITAL MANAGEMENT LP | $4397814 | 406077 | 0.39% | 股份 |
| Blue Owl Capital Holdings LP | $4332000 | 400000 | 0.39% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $4256948 | 393070 | 0.38% | 股份 |
| Redmile Group, LLC | $3920568 | 362010 | 0.35% | 股份 |
| Boxer Capital Management, LLC | $3790500 | 350000 | 0.34% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $3736762 | 345038 | 0.33% | 股份 |
| Squarepoint Ops LLC | $3729235 | 344343 | 0.33% | 股份 |
| Pfizer Inc | $3553775 | 372904 | 0.32% | 股份 |
| TD Asset Management Inc | $2664202 | 246002 | 0.24% | 股份 |
| CITIGROUP INC | $2647339 | 244445 | 0.24% | 股份 |
| BANK OF AMERICA CORP /DE/ | $2638892 | 243665 | 0.24% | 股份 |
| Trexquant Investment LP | $2402300 | 221819 | 0.21% | 股份 |
| XTX Topco Ltd | $2359066 | 217827 | 0.21% | 股份 |
| UBS Group AG | $2266578 | 209287 | 0.20% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1935321 | 178700 | 0.17% | 买入期权 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1886824 | 174222 | 0.17% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $1826241 | 168628 | 0.16% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1508251 | 139266 | 0.13% | 股份 |
| Jump Financial, LLC | $1423062 | 131400 | 0.13% | 股份 |
| Atom Investors LP | $1408756 | 130079 | 0.13% | 股份 |
| Ishara Investments LP | $1332090 | 123000 | 0.12% | 股份 |
| Caption Management, LLC | $1191300 | 110000 | 0.11% | 买入期权 |
| SPHERA FUNDS MANAGEMENT LTD. | $1083000 | 100000 | 0.10% | 买入期权 |
| Caption Management, LLC | $1083000 | 100000 | 0.10% | 卖出期权 |
| RHUMBLINE ADVISERS | $1017131 | 93919 | 0.09% | 股份 |
| Rafferty Asset Management, LLC | $982963 | 90763 | 0.09% | 股份 |
| Abu Dhabi Investment Council Co P.J.S.C | $968646 | 89441 | 0.09% | 股份 |
| Bank of New York Mellon Corp | $965776 | 89176 | 0.09% | 股份 |
| Swiss National Bank | $933546 | 86200 | 0.08% | 股份 |
| WINTON GROUP Ltd | $898890 | 83000 | 0.08% | 股份 |
| BlackRock, Inc. | $864407 | 79816 | 0.08% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $808473 | 63810 | 0.07% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $745169 | 68806 | 0.07% | 股份 |
| WELLS FARGO & COMPANY/MN | $696228 | 64287 | 0.06% | 股份 |
| Engineers Gate Manager LP | $693683 | 64052 | 0.06% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $612835 | 48369 | 0.05% | 股份 |
| Caption Management, LLC | $521248 | 48130 | 0.05% | 股份 |
| PROFUND ADVISORS LLC | $494931 | 45700 | 0.04% | 股份 |
| MetLife Investment Management, LLC | $474787 | 43840 | 0.04% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $459289 | 42409 | 0.04% | 股份 |
| Virtus Investment Advisers, LLC | $428489 | 39565 | 0.04% | 股份 |
| Optimize Financial Inc | $409596 | 32328 | 0.04% | 股份 |
| AXQ CAPITAL, LP | $395501 | 36519 | 0.04% | 股份 |
| Quadrature Capital Ltd | $393086 | 36296 | 0.04% | 股份 |
| LMR Partners LLP | $381942 | 35267 | 0.03% | 股份 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $372639 | 34408 | 0.03% | 股份 |
| AlphaQuest LLC | $363086 | 44387 | 0.03% | 股份 |
| Russell Investments Group, Ltd. | $332914 | 30740 | 0.03% | 股份 |
| Brevan Howard Capital Management LP | $331983 | 30654 | 0.03% | 股份 |
| Invesco Ltd. | $318456 | 29405 | 0.03% | 股份 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $310626 | 28682 | 0.03% | 股份 |
| Vanguard Global Advisers, LLC | $306457 | 28297 | 0.03% | 股份 |
| D. E. Shaw & Co., Inc. | $287103 | 26510 | 0.03% | 股份 |
| CITADEL ADVISORS LLC | $281580 | 26000 | 0.03% | 买入期权 |
| VANGUARD ASSET MANAGEMENT, Ltd | $272797 | 25189 | 0.02% | 股份 |
公司内部人士 11 位内幕人士 · 3 位高管 · 9 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Jacob Chacko | President and CEO | 2024年1月2日 A | 808544 | 0 | 0 | $0 |
| Dominic Piscitelli | Chief Financial Officer | 2024年1月2日 A | 83809 | 0 | 0 | $0 |
| Pratik S Multani | Chief Medical Officer | 2024年1月2日 A | 23809 | 0 | 0 | $0 |
| Richard A. Heyman | 董事 | 2026年7月24日 M | 206672 | 0 | 3 | $-161062 |
| Angie You | 董事 | 2023年6月14日 A | — | 0 | 0 | $0 |
| Mardi Dier | 董事 | 2023年6月14日 A | — | 0 | 0 | $0 |
| Lori Anne Kunkel | 董事 | 2023年6月14日 A | — | 0 | 0 | $0 |
| Steven L. Hoerter | 董事 | 2023年6月14日 A | — | 0 | 0 | $0 |
| Peter Svennilson | 董事 | 2021年6月16日 A | 4768181 | 0 | 0 | $0 |
| GORDON CARL L | 董事 | 2021年6月16日 A | 2212571 | 0 | 0 | $0 |
| Richard H Scheller | 董事 | 2021年5月24日 S | 39092 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| SR One Capital Management, LLC, SR One Capital Opportunities Fund I, LP, SR One Capital Opportunities Partners I, LP, AMZL, LP, SR One Capital SMA Partners, LP, SR One Capital Fund II Aggregator, LP, SR One Capital Partners II, LP, Simeon George ×2 申报 | 2025年8月14日 | 4.75% | 修订 | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VI LLC, OrbiMed Capital LLC ×5 申报 | 2022年12月27日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 43 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.78% | 29424 NS | 2026年4月30日 | N-PORT |
| CANC · Tema ETF Trust | 0.28% | 57977 NS | 2026年5月31日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.24% | 124292 NS | 2026年4月30日 | N-PORT |
| ESSC · Strategy Shares | 0.08% | 2136 NS | 2026年4月30日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.04% | 146225 NS | 2026年5月31日 | N-PORT |
| BIB · ProShares Trust | 0.04% | 3711 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.02% | 327184 NS | 2026年4月30日 | N-PORT |
| RSSL · Global X Funds | 0.02% | 28629 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 3114 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 365890 NS | 2026年5月31日 | N-PORT |
| UWM · ProShares Trust | 0.01% | 2435 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 20039 NS | 2026年4月30日 | N-PORT |
| URTY · ProShares Trust | 0.01% | 2463 NS | 2026年5月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 2102 NS | 2026年4月30日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 9920 NS | 2026年4月30日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.00% | 40897 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2346 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 30514 NS | 2026年4月30日 | N-PORT |
| HDG · ProShares Trust | 0.00% | 62 NS | 2026年5月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 97392 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 46809 NS | 2026年5月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 11258 NS | 2026年4月30日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 7147 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWN · iShares Trust | — | — | 2026年8月17日 | 每日 |
| IWO · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IBB · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWC · iShares Trust | — | — | 2026年8月18日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026年7月13日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |
| ISCB · iShares Trust | — | — | 2026年8月5日 | 每日 |
| ISCG · iShares Trust | — | — | 2026年8月5日 | 每日 |
| ISCV · iShares Trust | — | — | 2026年8月5日 | 每日 |
| WSML · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | — | — | 2026年7月20日 | 每日 |